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Background 
 Vegetarians account for around 6% of the population and popularity 
is increasing (Mintel 2008; FSA 2008, Craig 2009) 
 The removal of animal products from the diet can increase the risk of 
dietary deficiencies (Bailey 2009) 
 Vegetarian  diets are significantly lower in long chain omega-3 (n-3) 
fatty acids (LC3PUFA) than typical omnivorous diets (Conquer and 
Holub, 1997) 
 DHA is entirely absent from vegan diets (Sanders 2009) 
 Alpha-linolenic acid (18:3n-3; ALA) is currently the main vegetarian 
source of LC3PUFA 
 In the metabolic pathway ALA becomes eicosapentaenoic acid 
(20:5n-3; EPA) and docosahexaenoic acid (22:6n-3; DHA), although 
conversion is limited (Dephilippis and Sperling, 2005).   
 EPA is anti-thrombotic and thought to confer cardiovascular 
protection (Metcalf et al., 2007) 
 DHA has been linked to eye and brain development and is important 
for visual, cognitive and cardiovascular health (Arterburn et al., 2007) 
 Oily fish is currently the richest source of EPA and DHA 
 Some of the richest vegetarian sources of n-3 are oils obtained form 
flaxseed, walnut, echium seed and algae (Breivik 2007) 
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• Non fish sources of LC3PUFA are particularly important for vegetarians.  
• Conversion of the essential fatty acid ALA to EPA and DHA from foods or supplements is 
ineffective, leading scientists to seek further direct sources in the form of algae oils. 
• Interventions using algae oil have been successful in terms  of  DHA bioavailability, although 
further research is necessary to evaluate  dosages and suitability for the enrichment of 
functional foods. 
Conclusions 
Pubmed was searched for 
high quality, English-
language, peer reviewed 
intervention studies 
published in the last ten 
years. 
 
Search terms included: 
bioavailability, supplement, 
ALA α-linolenic acid, alpha-
linolenic acid and the 
current richest sources 
flaxseed, walnut, echium 
and algae.  
 
Human intervention (HI) 
and randomised controlled 
(RCT) studies that 
measured bioavailability 
with suitable blood 
analytes (blood plasma 
and/or erythrocytes) were 
selected. 
 Non fish sources of LC3PUFA are particularly important for vegetarians 
 Conversion of the essential fatty acid ALA to EPA and DHA from foods 
or supplements is ineffective 
 Oils produced from marine-algae sources are fully vegetarian and 
suitable for vegans; they  could be used to provide a direct, vegetarian 
source of DHA  
 Unlike the other vegetarian sources  algae oil supplements  and 
fortified foods gave increases in plasma and erythrocyte DHA levels 
using relatively small doses  
 Bioavailability was greater for an algae oil fortified food than 
supplements 
 Algae oils were well tolerated; adverse event monitoring in the studies 
revealed an excellent safety and tolerability profile  
 As algae oils do not occur in regular foods, a nutritional vehicle would 
be necessary to incorporate them into the diet  
 Suitable foods appropriate for fortification or enrichment with algae 
oils need to be identified and evaluated 
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Figure 1.  The long chain polyunsaturated fatty acid metabolic pathway  
(Kirby et al., 2009) 
Male Female  
Fatty acid Vegan Omnivore Vegan Omnivore 
ALA 1.8±0.37 1.0±0.017 1.2±0.22 1.1±0.02 
EPA ND* 0.02±0.05 ND* 0.09±0.02 
DHA ND* 0.42±0.23 ND* 0.04±0.02 
Table 2.  Intakes of LC3PUFA in vegans and omnivores 
ND = not detected, *P<0.01, two-sample t-test compared with value for same gender  (Adapted from Sanders 2009) 
Adapted from Lane et al (2012) 
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Arterburn 
et al. 
(2007) 
RCT with healthy subjects
Algae 
DHA oil 
1g/d 
(DHA)
96 M & F
4 
weeks 
Zhao et 
al. 
(2004) 
RCT in healthy subjects 
with elevated cholesterol 
levels
English 
walnut oil 
15g/d 
(1.5g 
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23 M & F 
6 
weeks 
(per 
diet)
N/S
 + 
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Surette 
et al. 
(2004) 
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cholesterol 
Echium 
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(3g ALA)
11 M & F 
4 
weeks 
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significant)
François 
et al. 
(2003) 
HI with breast feeding 
mothers 
Flaxseed 
oil 20g 
(10.7g 
ALA)
7 F
4 
weeks 
Barcelo-
Coblijn 
et al. 
(2008) 
RCT with Canadian fire-
fighters. 
Flaxseed 
oil 1.2 to 
3.6g/d 
(0.6 to 
1.8g 
ALA)
62 M & F
12 
weeks
+ + N/S + + N/S
+ N/S
Key: RCT= Randomised control trial, SB= Single blinded, DB= Double blinded, M= Male, F= 
Female, PL= Plasma, RBC = Red blood cells 
